A detailed history of Riverview Trust CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Riverview Trust CO holds 487 shares of IONS stock, worth $16,426. This represents 0.02% of its overall portfolio holdings.

Number of Shares
487
Previous 476 2.31%
Holding current value
$16,426
Previous $22,000 13.64%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$40.06 - $51.86 $440 - $570
11 Added 2.31%
487 $19,000
Q1 2024

Apr 12, 2024

BUY
$42.03 - $53.55 $20,006 - $25,489
476 New
476 $20,000
Q1 2022

Apr 21, 2022

BUY
$29.88 - $37.04 $14,222 - $17,631
476 New
476 $18,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.79B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.